The fifth edition of Make it in the Emirates, held at ADNEC Centre Abu Dhabi from May 4–7, drew more than 1,200 exhibitors across 88,000 square metres, cementing advanced manufacturing as a cornerstone of UAE economic strategy.
The Sharjah Business Women Council (SBWC) has inaugurated a new business hub at Al Mamsha, creating a dedicated space for women entrepreneurs to network, exchange knowledge, and access practical support.
UAE master developer Arada is rolling out a four-hospital healthcare network backed by AED 2 billion in total investment, as the company accelerates its shift away from purely residential revenues.
The UAE welcomed more than 32 million hotel guests in 2025, generating Dh49.2 billion in hotel revenues – a 9.7% year-on-year increase – according to the Emirates Tourism Council's annual sector report.
Bahrain's sovereign wealth fund Mumtalakat recorded an 87% jump in net profit for 2025, with earnings attributable to shareholders rising to BHD 593 million (USD 1.6 billion) from BHD 317 million the prior year.
Dubai's real estate market recorded AED 21 billion in transactions over the past week, according to the Dubai Land Department, extending a sustained run of elevated weekly volumes that has seen recent weeks register AED 15.2 billion and AED 14.7 billion respectively.
Aldar has sold out Al Ghadeer Gardens on its launch day, generating more than AED 1 billion in sales from the 437-villa and townhouse community positioned along the Abu Dhabi-Dubai border.
The UK and Gulf Cooperation Council (GCC) have finalised a free trade agreement after four years of negotiations, creating a framework intended to expand bilateral trade and strengthen investment protections across both blocs.
UAE-based AI infrastructure firm Core42 has secured USD 550 million through two structured trade finance facilities from HSBC, earmarked for accelerating its AI cloud and compute deployments across the US and Europe.
Abu Dhabi's MGX has joined a USD 2.1 billion Series B funding round for Isomorphic Labs, a UK-based AI-driven drug design company.
Sign up for our free newsletter